HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Abstract
The recent approval of oncolytic virus for therapy of melanoma patients has increased the need for precise evaluation of the mechanisms by which oncolytic viruses affect tumor growth. Here we show that the human NK cell-activating receptor NKp46 and the orthologous mouse protein NCR1 recognize the reovirus sigma1 protein in a sialic-acid-dependent manner. We identify sites of NKp46/NCR1 binding to sigma1 and show that sigma1 binding by NKp46/NCR1 leads to NK cell activation in vitro Finally, we demonstrate that NCR1 activation is essential for reovirus-based therapy in vivo Collectively, we have identified sigma1 as a novel ligand for NKp46/NCR1 and demonstrated that NKp46/NCR1 is needed both for clearance of reovirus infection and for reovirus-based tumor therapy.IMPORTANCE Reovirus infects much of the population during childhood, causing mild disease, and hence is considered to be efficiently controlled by the immune system. Reovirus also specifically infects tumor cells, leading to tumor death, and is currently being tested in human clinical trials for cancer therapy. The mechanisms by which our immune system controls reovirus infection and tumor killing are not well understood. We report here that natural killer (NK) cells recognize a viral protein named sigma1 through the NK cell-activating receptor NKp46. Using several mouse tumor models, we demonstrate the importance of NK cells in protection from reovirus infection and in reovirus killing of tumors in vivo Collectively, we identify a new ligand for the NKp46 receptor and provide evidence for the importance of NKp46 in the control of reovirus infections and in reovirus-based cancer therapy.
AuthorsYotam Bar-On, Yoav Charpak-Amikam, Ariella Glasner, Batya Isaacson, Alexandra Duev-Cohen, Pinchas Tsukerman, Alexander Varvak, Michal Mandelboim, Ofer Mandelboim
JournalJournal of virology (J Virol) Vol. 91 Issue 19 (10 01 2017) ISSN: 1098-5514 [Electronic] United States
PMID28724773 (Publication Type: Journal Article)
CopyrightCopyright © 2017 American Society for Microbiology.
Chemical References
  • Antigens, Ly
  • Natural Cytotoxicity Triggering Receptor 1
  • Ncr1 protein, mouse
  • Viral Proteins
  • N-Acetylneuraminic Acid
Topics
  • Animals
  • Antigens, Ly (metabolism)
  • Binding Sites
  • Chlorocebus aethiops
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Killer Cells, Natural (immunology)
  • Lymphocyte Activation (immunology)
  • Mammalian orthoreovirus 3 (metabolism)
  • Melanoma (therapy)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • N-Acetylneuraminic Acid (metabolism)
  • Natural Cytotoxicity Triggering Receptor 1 (metabolism)
  • Oncolytic Virotherapy (methods)
  • Oncolytic Viruses (metabolism)
  • Vero Cells
  • Viral Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: